Loading clinical trials...
Loading clinical trials...
Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta in a High Risk Population
Conditions
Interventions
Women at high risk of MAP
Locations
1
France
Angers University Hospita
Angers, France
Start Date
November 1, 2013
Primary Completion Date
November 1, 2015
Completion Date
November 1, 2016
Last Updated
May 27, 2016
NCT05139498
NCT07406841
NCT07236060
NCT07129135
NCT05471102
NCT06808165
Lead Sponsor
University Hospital, Angers
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions